Hello, everyone, and how are you this morning? Despite some tech challenges today, we are hanging in there, as they say. Our official mascot is undeterred and scurrying about the Pharmalot campus. As for us, we are attempting to go about our usual routine, which includes a cup of stimulation and gazing out the window at delightfully sunny skies. Now, though, the time has come to get cracking. So here are a few items of interest to help you along. Hope your day goes well and you have no trouble making your own connections. …
The White House stunned health care experts last month when it declared it was abandoning its efforts to reform drug pricing in the major domestic spending package moving through Congress, but unlike earlier in the talks, moderate Democrats weren’t the holdouts. This time, it was Speaker Nancy Pelosi who dealt the blow, STAT tells us. It was her behind-the-scenes opposition, which has not been previously reported, that prompted the White House to declare the issue dead — a surprising role for Pelosi, given her decades of long support for sweeping efforts to lower drug prices. The multiple near-collapses and resurrections of the recent negotiations over drug-pricing reform underscore how momentous it was, for Democrats, when they finally did announce a drug pricing deal last week.
Create a display name to comment
This name will appear with your comment